版权说明 操作指南
首页 > 成果 > 详情

Circulating small extracellular vesicles microRNAs plus CA-125 for treatment stratification in advanced ovarian cancer

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Zhou, Xiaofang;Liu, Mu;Sun, Lijuan;Cao, Yumei;Tan, Shanmei;...
通讯作者:
Tang, J
作者机构:
[Tang, J; Wan, Ziqing; Zhou, Xiaofang; Tang, Jie; Liu, Mu] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Dept Gynecol Oncol,Xiangya Sch Med, Changsha 410013, Peoples R China.
[Cao, Yumei; Sun, Lijuan] Cent Hosp Shaoyang, Dept Gynecol & Obstet, Shaoyang 422000, Peoples R China.
[Luo, Guangxia; Tan, Shanmei] Univ South China, Peoples Hosp Huaihua 1, Dept Gynecol & Obstet, Affiliated Huaihua Hosp, Huaihua 418000, Peoples R China.
[Liu, Tingting] First Peoples Hosp Changde, Dept Gynecol & Obstet, Changde 415000, Peoples R China.
[Yao, Ying; Xiao, Wangli] First Peoples Hosp Yueyang, Dept Gynecol & Obstet, Yueyang 414000, Peoples R China.
通讯机构:
[Tang, J ] C
Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Dept Gynecol Oncol,Xiangya Sch Med, Changsha 410013, Peoples R China.
Cent South Univ, Xiangya Sch Med, Hunan Canc Hosp, Dept Gynecol Oncol,Hunan Gynecol Canc Res Ctr,Aff, 283 Tongzipo Rd, Changsha 410013, Peoples R China.
语种:
英文
关键词:
Ovarian cancer;Residual disease;Small extracellular vesicles;microRNA;Prediction model
期刊:
Journal of Translational Medicine
ISSN:
1479-5876
年:
2023
卷:
21
期:
1
页码:
1-19
基金类别:
This work was supported by Grants from the General Project of Natural Science Foundation of Hunan Province (No. 2020JJ4051); Promotion Project of Health Suitability Program in Health Department of Hunan Province (No. WZ2020-15); Science and Technology Innovation Program of Hunan Province (No. 2020SK51101); Hunan Cancer Hospital Climbing Fund (No. ZX2020004); Capacity Building Project of Central Subsidy Medical and Health Institutions (No. 20201127-1001); Key Specialty Construction Project in Hunan Province (No. 20210826-1004); General Project in Health Department of Hunan Province (No. 202205015388).
机构署名:
本校为其他机构
摘要:
BACKGROUND: No residual disease (R0 resection) after debulking surgery is the most critical independent prognostic factor for advanced ovarian cancer (AOC). There is an unmet clinical need for selecting primary or interval debulking surgery in AOC patients using existing prediction models. METHODS: RNA sequencing of circulating small extracellular vesicles (sEVs) was used to discover the differential expression microRNAs (DEMs) profile between any residual disease (R0, n = 17) and no residual disease (non-R0, n = 20) in AOC patients. We fur...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com